On the other hand, IFNβ can stimulate the mobilization of immune cells such as dendritic cells (DCs) and T cells, and induce the presentation of tumor-associated antigens or neoantigens by MHC molecules on the surface of DCs to CD8+ T cells, thus eliciting an antitumor immune response (27, 44). The gene discussed is HLA-C; the disease is neoplasm.